IGM Biosciences Inc (IGMS)
9.18
-0.11
(-1.18%)
USD |
NASDAQ |
May 17, 16:00
9.18
0.00 (0.00%)
After-Hours: 20:00
IGM Biosciences Accounts Payable (Quarterly): 3.995M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 3.995M |
| December 31, 2023 | 1.326M |
| September 30, 2023 | 3.913M |
| June 30, 2023 | 4.936M |
| March 31, 2023 | 3.972M |
| December 31, 2022 | 2.512M |
| September 30, 2022 | 2.731M |
| June 30, 2022 | 3.459M |
| March 31, 2022 | 4.011M |
| December 31, 2021 | 5.584M |
| September 30, 2021 | 3.345M |
| Date | Value |
|---|---|
| June 30, 2021 | 4.853M |
| March 31, 2021 | 5.661M |
| December 31, 2020 | 7.924M |
| September 30, 2020 | 3.189M |
| June 30, 2020 | 4.264M |
| March 31, 2020 | 1.984M |
| December 31, 2019 | 3.087M |
| September 30, 2019 | 2.778M |
| June 30, 2019 | 2.134M |
| December 31, 2018 | 0.164M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
1.326M
Minimum
Dec 2023
7.924M
Maximum
Dec 2020
3.783M
Average
3.686M
Median
Accounts Payable (Quarterly) Benchmarks
| Akoya Biosciences Inc | 10.75M |
| Xilio Therapeutics Inc | 0.746M |
| NovaBay Pharmaceuticals Inc | 1.117M |
| Palatin Technologies Inc | 3.443M |
| iBio Inc | 1.859M |